Wells Fargo’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-74,394
| Closed | -$1.24M | – | 6711 |
|
|
2017
Q3 | $1.24M | Sell |
74,394
-11,515
| -13% | -$187K | ﹤0.01% | 3690 |
|
|
2017
Q2 | $1.54M | Sell |
85,909
-7,451
| -8% | -$139K | ﹤0.01% | 3397 |
|
|
2017
Q1 | $1.87M | Sell |
93,360
-33,655
| -26% | -$784K | ﹤0.01% | 3261 |
|
|
2016
Q4 | $3.18M | Sell |
127,015
-9,639
| -7% | -$228K | ﹤0.01% | 2769 |
|
|
2016
Q3 | $3.19M | Buy |
136,654
+7,110
| +5% | +$167K | ﹤0.01% | 2615 |
|
|
2016
Q2 | $2.59M | Sell |
129,544
-11,361
| -8% | -$212K | ﹤0.01% | 2782 |
|
|
2016
Q1 | $2.39M | Sell |
140,905
-30,980
| -18% | -$635K | ﹤0.01% | 2796 |
|
|
2015
Q4 | $3.82M | Sell |
171,885
-13,641
| -7% | -$284K | ﹤0.01% | 2523 |
|
|
2015
Q3 | $3.15M | Sell |
185,526
-5,872
| -3% | -$91.4K | ﹤0.01% | 2644 |
|
|
2015
Q2 | $2.63M | Sell |
191,398
-21,358
| -10% | -$284K | ﹤0.01% | 2889 |
|
|
2015
Q1 | $2.91M | Sell |
212,756
-25,696
| -11% | -$296K | ﹤0.01% | 2764 |
|
|
2014
Q4 | $2.52M | Buy |
238,452
+112,056
| +89% | +$1.33M | ﹤0.01% | 2838 |
|
|
2014
Q3 | $1.58M | Sell |
126,396
-1,013
| -0.8% | -$14.1K | ﹤0.01% | 3143 |
|
|
2014
Q2 | $1.74M | Buy |
127,409
+31,983
| +34% | +$418K | ﹤0.01% | 3081 |
|
|
2014
Q1 | $1.15M | Buy |
95,426
+8,687
| +10% | +$99.5K | ﹤0.01% | 3398 |
|
|
2013
Q4 | $1.07M | Buy |
86,739
+18,355
| +27% | +$215K | ﹤0.01% | 3366 |
|
|
2013
Q3 | $695K | Buy |
68,384
+66,384
| +3,319% | +$621K | ﹤0.01% | 3575 |
|
|
2013
Q2 | $18K | Buy |
+2,000
| New | +$20.1K | ﹤0.01% | 4912 |
|
Wells Fargo's OME Position: Q4 2017 in Review
Wells Fargo sold out of Omega Protein (OME) in Q4 2017, closing a stake of 74,394 shares — an estimated $1.24M sold.
Wells Fargo first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $3.82M in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Wells Fargo reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Wells Fargo sold 74,394 Omega Protein shares in Q4 2017, an estimated $1.24M.
- Wells Fargo first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Wells Fargo's Omega Protein position peaked at $3.82M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.